cell
cultur
spodoptera
frugipurda
cell
routin
cultur
medium
life
scienc
suspens
cultur
plaqu
assay
cell
allow
settl
onto
polystyren
dish
h
viru
inocul
viru
adsorpt
cell
sequenti
overlaid
low
meltingtemperatur
agaros
supplement
fetal
calf
serum
cultur
day
stain
neutral
red
vector
construct
cdna
encod
fulllength
protein
minu
signal
peptid
transmembran
tm
domain
aa
hong
kong
isol
scov
suppli
andrew
davidson
stuart
siddel
univers
bristol
bristol
uk
reversetranscript
poli
meras
chain
reactionamplifi
fragment
first
clone
ptopo
invitrogen
sever
overlap
fragment
protein
end
point
chosen
bioinformat
analysi
amplifi
origin
clone
fragment
gener
flank
dissimilar
restrict
site
enzym
sfii
fragment
clone
set
vector
variant
provid
histag
maltos
bind
proteintag
cell
surfacedisplay
form
protein
cell
surfacedisplay
cassett
describ
detail
bac
uloviru
display
transfer
vector
pacvsvgtm
modifi
includ
sfii
site
junction
signal
peptid
vesicular
stomat
viru
vsv
g
protein
tm
domain
use
provid
express
cell
surfac
express
insect
cell
express
insect
cell
recombin
baculovirus
construct
use
new
rapid
recombin
techniqu
cotransfect
ofeachtransf
vector
linear
modifi
form
bacmid
dna
capabl
growth
recombin
coexpress
mous
furin
human
calnexin
done
coinfect
virus
moi
wb
protein
sampl
analyz
separ
precast
trishcl
sdspolyacrylamid
gel
biorad
transfer
onto
immobilonp
transfer
membran
millipor
wb
perform
human
convalescentphas
serum
rabbit
serum
vsv
g
protein
tm
domain
research
diagnost
follow
peroxidasecoupl
secondari
antibodi
sigma
membran
final
develop
use
bm
chemiluminesc
roch
fac
analysi
flow
cytometri
cell
plate
plate
cellswel
overlaid
ml
medium
viru
inocul
cell
cultur
day
harvest
wash
pb
fix
cellfix
becton
dickinson
stain
serum
conjug
data
acquisit
analysi
perform
use
facscan
flow
cytomet
cellquest
softwar
becton
dickinson
human
serum
serum
sampl
patient
sar
human
cov
obtain
respiratori
diseas
refer
laboratori
health
protect
agenc
colindal
uk
nine
probabl
sar
case
occur
unit
kingdom
conform
clinic
definit
sar
use
time
serum
sampl
patient
known
posit
sar
deriv
patient
clinic
confirm
case
wherea
serum
sampl
use
probabl
unconfirm
sar
case
deriv
remain
patient
patient
recov
sar
human
cov
serum
sampl
avail
present
studi
reactiv
cov
sar
protein
could
assess
similarli
serum
sampl
cov
patient
avail
serum
sampl
use
fac
wb
analys
dilut
respect
unless
otherwis
state
timecours
serum
sampl
avail
patient
confirm
sar
assay
use
elisa
use
lentil
lectincaptur
fulllength
protein
endpoint
titer
compar
class
antibodi
bound
ascertain
use
classspecif
secondari
antihuman
antibodi
sigma
express
character
recombin
scov
protein
scov
protein
residu
glycosyl
triplet
cluster
toward
amino
carboxyl
termini
glycosyl
protein
fold
often
link
focus
express
studi
use
highyield
eukaryoticbas
express
system
baculovirusmedi
express
insect
cell
examin
number
biochem
featur
character
protein
express
use
antibodi
bind
protein
signal
peptid
tm
domain
substitut
region
known
function
well
express
systema
signal
peptid
major
baculoviru
glycoprotein
tm
domain
vsv
g
protein
alreadi
present
pacvsv
gtm
vector
effici
display
protein
surfac
insect
cell
method
express
maintain
conform
integr
even
problemat
protein
addit
fulllength
protein
fragment
repres
predominantli
domain
residu
respect
fragment
n
terminu
residu
predict
form
distinct
fold
domain
analyz
fold
predic
softwar
fragment
repres
residu
express
way
figur
abund
express
protein
fragment
achiev
use
strategi
shown
wb
vsv
gtm
domain
antibodi
show
predomin
band
construct
repres
nonglycosyl
glycosyl
protein
appar
molecular
weight
consist
predict
figur
interact
calnexin
protein
cleavag
protein
cov
heavili
glycosyl
improp
glycan
trim
result
poor
surfaceexpress
level
retent
viral
glycoprotein
glycoprotein
chaperon
calnexin
assess
whether
calnexin
pathway
relev
express
protein
coinfect
recombin
fulllength
protein
virusexpress
calnexin
reexamin
level
glycosyl
nonglycosyl
protein
day
infect
compar
express
protein
coexpress
protein
calnexin
led
increas
ratio
glycosyl
nonglycosyl
product
calcul
use
gel
scan
figur
show
protein
interact
calnexin
glycosyl
howev
overal
increas
protein
yield
observ
despit
improv
glycoprotein
process
cov
protein
cleav
around
center
molecul
form
receptorbind
outer
domain
innermembran
fusion
domain
fulllength
protein
cleav
insect
cell
fulli
glycosyl
form
appar
molecular
weight
kda
figur
assess
potenti
protein
cleav
proteas
subtilisinlik
furin
provid
coinfect
describ
elsewher
trypsin
ad
exogen
furin
classic
viral
glycoprotein
matur
enzym
consensu
furin
cleavag
site
occur
protein
sequenc
sever
dibas
site
also
recogn
enzym
present
allow
possibl
furin
cleavag
recombin
protein
produc
presenc
coexpress
furin
show
evid
cleavag
figur
suggest
furin
associ
scov
envelop
matur
protein
surfac
infect
insect
cell
also
treat
trypsin
condit
found
cleav
murin
cov
reanalyz
cleavag
reaction
wb
use
vsv
gtm
domain
patient
antibodi
treatment
trypsin
caus
loss
glycosyl
protein
band
concomit
appear
new
band
intens
kda
whose
mobil
indistinguish
shown
junction
chosen
wholli
basi
predict
secondari
structur
residu
singl
ly
residu
occur
posit
basi
data
suggest
trypsin
access
protein
nondenatur
condit
cleav
ly
produc
domain
domain
interestingli
molecular
model
scov
protein
also
suggest
junction
lie
within
amino
acid
sequenc
protein
found
nonpellet
fraction
addit
trypsin
suggest
protein
domain
remain
associ
even
cleavag
data
shown
probe
patient
serum
sampl
presum
domain
kda
also
highlight
also
number
smaller
breakdown
product
distinct
band
predict
size
domain
visibl
suggest
degrad
trypsin
detect
effici
avail
human
serum
sampl
see
whether
protein
cleav
scov
cell
entri
remain
undetermin
reactiv
human
serum
sampl
abund
stabl
character
surfac
express
suit
proteinrel
fragment
prompt
us
use
reagent
investig
antibodi
respons
protein
serum
sampl
infect
individu
serum
sampl
use
obtain
sever
uk
patient
patient
detail
see
materi
method
addit
serum
sampl
repres
time
cours
diseas
onset
obtain
refer
patient
assess
reactiv
serum
sampl
fragment
use
flow
cytometri
wb
repres
nativ
denatur
sourc
antigen
respect
cytometri
profil
show
greatest
reactiv
patient
serum
sampl
protein
fragment
also
react
except
aa
repres
middl
section
code
region
fail
react
significantli
patient
serum
sampl
despit
high
level
express
figur
gener
pattern
bind
appar
patient
serum
sampl
although
exact
degre
reactiv
fragment
vari
somewhat
serum
sampl
shown
figur
data
serum
sampl
typic
pattern
serum
reactiv
assess
use
wb
howev
pattern
bind
substanti
differ
reactiv
seen
fulllength
protein
strong
bind
also
seen
figur
bottom
one
serum
sampl
broadli
reactiv
sampl
show
reactiv
weak
compar
fragment
span
ctermin
half
protein
wholli
absent
serum
sampl
typifi
wb
use
serum
sampl
figur
bottom
quantit
serum
respons
protein
densitometri
wb
rel
fluoresc
fac
gave
reactiv
order
other
respect
figur
thu
clear
shift
reactiv
serum
sampl
depend
assay
format
specif
serum
reactiv
protein
fragment
possibl
use
insect
celldisplay
protein
diagnost
applic
assess
examin
fragment
reactiv
serum
sampl
patient
infect
human
cov
also
serum
patient
suspect
clinic
unconfirm
sar
serum
sampl
preliminari
data
indic
serum
sampl
cov
individu
crossreact
purifi
scov
nucleocapsid
protein
ph
mz
unpublish
data
use
specif
test
seroconvers
base
protein
may
valuabl
serum
sampl
patient
confirm
cov
infect
react
use
fac
figur
wherea
serum
sampl
patient
suspect
sar
show
weak
clear
shift
fluoresc
wb
could
also
distinguish
serum
sampl
although
discrimin
sampl
good
achiev
use
fac
data
shown
suggest
discriminatori
test
uncertain
case
use
optim
protein
fragment
present
nondenatur
assay
format
time
cours
antibodi
respons
set
serum
sampl
repres
time
cours
day
onset
sar
patient
obtain
use
proteinspecif
elisa
determin
increas
protein
titer
time
titer
protein
antibodi
signific
day
similar
serum
respons
report
whole
infect
cell
isol
n
protein
increas
latest
time
point
day
onset
figur
serum
sampl
also
use
wb
assay
examin
chang
reactiv
individu
protein
fragment
time
earliest
wbposit
serum
sampl
day
onset
gave
pattern
bind
similar
serum
sampl
test
figur
time
point
provid
much
stronger
signal
pattern
bind
alter
figur
blot
also
probe
isotypespecif
conjug
result
compar
blot
probe
iggspecif
conjug
found
evid
develop
igm
respons
late
recoveri
period
weak
compar
igg
data
shown
serum
antibodi
avail
present
studi
remain
possibl
secret
antibodi
also
present
respiratori
secret
earli
infect
data
provid
first
profil
antibodi
bind
scov
protein
effici
express
protein
specif
sourc
antigen
achiev
use
highli
product
express
system
recombin
baculovirus
combin
use
signal
tm
sequenc
proven
effici
direct
protein
surfac
express
cell
format
offer
assay
base
antibodi
bind
cell
surfac
mimick
infect
cell
singularli
high
level
express
protein
well
denatur
antigen
prepar
cell
lysi
character
express
product
provid
evid
potenti
interact
known
glycoprotein
chaperon
calnexin
although
stimul
glycan
process
margin
total
cleavag
protein
trypsinlik
furin
proteas
cleavag
surfac
glycoprotein
key
factor
pathogenesi
virus
interest
evalu
role
protein
cleavag
scov
infect
anim
human
host
present
studi
fulllength
protein
surfac
insect
cell
bind
varieti
speci
red
blood
cell
suggest
hemagglutin
protein
releas
deterg
lysi
also
fail
bind
discret
protein
farwestern
blot
assay
vero
cell
membran
data
shown
accordingli
data
address
natur
receptor
scov
particular
earli
suggest
may
recent
data
show
angiotensinconvert
enzym
least
function
scov
receptor
effici
sourc
sever
recombin
protein
fragment
allow
us
evalu
predomin
antibodi
present
convalesc
serum
sampl
interestingli
pattern
reactiv
avail
serum
sampl
similar
within
assay
format
suggest
immun
respons
protein
vari
quantit
individu
result
would
keep
appar
low
immunolog
pressur
suggest
sequenc
variat
observ
sever
isol
assay
format
use
nondenatur
protein
present
cell
surfac
provid
sensit
detect
antibodi
clear
shift
fluoresc
serum
sampl
patient
suspect
clinic
unconfirm
sar
shift
appar
human
cov
serum
sampl
suggest
format
highli
specif
reactiv
posit
serum
sampl
individu
protein
fragment
compar
observ
strong
differenti
bind
depend
assay
use
thu
although
fac
show
highest
reactiv
fragment
includ
amino
terminu
protein
wb
serum
sampl
show
preferenti
reactiv
carboxyl
termin
half
molecul
differenti
antibodi
bind
influenc
highmannos
glycan
present
insectderiv
glycoprotein
protein
prepar
mimic
cell
invitrogen
add
complex
glycan
polypeptid
show
pattern
reactiv
serum
sampl
use
data
shown
data
obtain
serum
sampl
patient
sar
avail
unit
kingdom
clearli
requir
confirm
larger
set
serum
sampl
would
consist
level
conform
antibodi
present
serum
sampl
preferenti
direct
toward
globular
n
terminu
protein
detect
use
fac
use
wb
class
antibodi
includ
use
diagnosi
see
suggest
suitabl
assay
format
final
diagnost
best
configur
authent
fold
protein
rather
exampl
peptid
preliminari
work
purifi
solubl
fulllength
protein
suggest
sensit
maintain
solubl
protein
indic
assay
format
simpler
flow
cytometri
feasibl
confirm
class
conform
antibodi
direct
globular
domain
includ
neutral
antibodi
whether
bear
outcom
infect
import
recombin
protein
also
consid
part
possibl
vaccin
scov
infect
